content top

DePuy ASR Hip Lawsuit News: New Jersey Case ‘Resolved,’ Rottenstein Law Group LLP Reports

Bergen County District Court in New Jersey has deemed a DePuy ASR hip lawsuit “resolved” and removed the matter from its trial calendar, according to court documents. The Rottenstein Law Group LLP, which maintains a comprehensive DePuy settlements informational website, notes that if the case has settled out of court then it will join a growing list of ASR lawsuits similarly resolved. Read more at DePuy ASR Hip Lawsuit News: New Jersey...

Read More

DePuy ASR Hip Lawsuit News: Settlement Reached in California Hip Case, Rottenstein Law Group LLP Reports

Johnson & Johnson subsidiary DePuy Orthopaedics has agreed to settle a DePuy ASR hip lawsuit before what would have been the first bellwether trial in a California state court consolidation of ASR cases. The Rottenstein Law Group LLP, which maintains the hip implant informational website http://www.depuysettlements.com, notes that the settlement joins a growing list of current and potential ASR settlements. Read more at PRWeb.com...

Read More

New York’s Finest for September 2013

For most New Yorkers and tourists from all over the world, Big Apple is probably the best place to be if you’re looking for fun, adventure and enjoyment. New York City is considered to be the busiest place on earth. It probably is the perfect spot for people who are into fashion, arts, culture, business and many others. Its versatility has attracted so many people to visit the place and maybe come back for more. Here is a line-up of...

Read More

You Want Robotic-assisted Surgery? Consider This Criteria

There are several markers that may help surgeons decide the best plan action for certain patients, health care providers say, as some men and women have are more prone to experience complications than others. There are no surgical procedures that do not have any risk for the patient as even minimally invasive procedures have criteria that are followed, according to the University of California Davis Health System, indicating that some...

Read More

Merck Announces FDA Acceptance of New Drug Application for Januvia

Januvia has been accepted for standard review by the Food and Drug Administration, Merck & Co announced in a press statement referring to the February 16, 2006 approval on the new formulation. The company’s investigational medicine for type 2 diabetes was made the first in a new class of oral medications in the United States and planned to be the first one across the world according to www.drugs.com. An oral inhibitor for the...

Read More
content top